Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 336

    1.

    Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation.

    Mari A, Tura A, Gastaldelli A, Ferrannini E.

    Diabetes. 2002 Feb;51 Suppl 1:S221-6.PMID: 11815483 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects.

    Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E.

    Am J Physiol Endocrinol Metab. 2002 Dec;283(6):E1159-66. Epub 2002 Aug 6.PMID: 12388151 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Characterization of beta-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal tests.

    Mari A, Gastaldelli A, Natali A, Ostergard T, Schmitz O, Ferrannini E.

    Am J Physiol Endocrinol Metab. 2005 Mar;288(3):E541-6. Epub 2004 Nov 2.PMID: 15522997 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.

    Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ.

    J Clin Endocrinol Metab. 2003 Jun;88(6):2706-13.PMID: 12788877 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.

    Shapiro ET, Van Cauter E, Tillil H, Given BD, Hirsch L, Beebe C, Rubenstein AH, Polonsky KS.

    J Clin Endocrinol Metab. 1989 Sep;69(3):571-6.PMID: 2503533 [PubMed - indexed for MEDLINE]Related articles

    6.

    Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects.

    Levy JC, Rudenski A, Burnett M, Knight R, Matthews DR, Turner RC.

    Diabetologia. 1991 Jul;34(7):488-99.PMID: 1916054 [PubMed - indexed for MEDLINE]Related articles

    7.

    Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.

    Greenbaum CJ, Prigeon RL, D'Alessio DA.

    Diabetes. 2002 Apr;51(4):951-7.PMID: 11916912 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Characterization of GLP-1 effects on beta-cell function after meal ingestion in humans.

    Ahrén B, Holst JJ, Mari A.

    Diabetes Care. 2003 Oct;26(10):2860-4.PMID: 14514592 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes.

    Mari A, Sallas WM, He YL, Watson C, Ligueros-Saylan M, Dunning BE, Deacon CF, Holst JJ, Foley JE.

    J Clin Endocrinol Metab. 2005 Aug;90(8):4888-94. Epub 2005 May 10.PMID: 15886245 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Pancreatic beta-cell responsiveness during meal tolerance test: model assessment in normal subjects and subjects with newly diagnosed noninsulin-dependent diabetes mellitus.

    Hovorka R, Chassin L, Luzio SD, Playle R, Owens DR.

    J Clin Endocrinol Metab. 1998 Mar;83(3):744-50.PMID: 9506719 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans.

    Quddusi S, Vahl TP, Hanson K, Prigeon RL, D'Alessio DA.

    Diabetes Care. 2003 Mar;26(3):791-8.PMID: 12610039 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Type 2 diabetes mellitus in African-American adolescents: impaired beta-cell function in the face of severe insulin resistance.

    Taha D, Umpaichitra V, Banerji MA, Castells S.

    J Pediatr Endocrinol Metab. 2006 Feb;19(2):135-42.PMID: 16562586 [PubMed - indexed for MEDLINE]Related articles

    13.

    Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus--"Flatbush diabetes".

    Banerji MA.

    J Pediatr Endocrinol Metab. 2002 Apr;15 Suppl 1:493-501. Review.PMID: 12017222 [PubMed - indexed for MEDLINE]Related articles

    14.

    A model for glucose control of insulin secretion during 24 h of free living.

    Mari A, Camastra S, Toschi E, Giancaterini A, Gastaldelli A, Mingrone G, Ferrannini E.

    Diabetes. 2001 Feb;50 Suppl 1:S164-8.PMID: 11272182 [PubMed - indexed for MEDLINE]Related articles

    15.

    The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects.

    Kjems LL, Holst JJ, Vølund A, Madsbad S.

    Diabetes. 2003 Feb;52(2):380-6.PMID: 12540611 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    NEFA-glucose comodulation model of beta-cell insulin secretion in 24-h multiple-meal test.

    Salinari S, Bertuzzi A, Manco M, Mingrone G.

    Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1890-8. Epub 2007 Mar 6.PMID: 17341546 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Quantification of beta-cell function during IVGTT in Type II and non-diabetic subjects: assessment of insulin secretion by mathematical methods.

    Kjems LL, Vølund A, Madsbad S.

    Diabetologia. 2001 Oct;44(10):1339-48.PMID: 11692185 [PubMed - indexed for MEDLINE]Related articles

    18.

    beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis.

    Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA.

    J Clin Endocrinol Metab. 2005 Jan;90(1):493-500. Epub 2004 Oct 13.PMID: 15483086 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    beta-cell function in morbidly obese subjects during free living: long-term effects of weight loss.

    Camastra S, Manco M, Mari A, Baldi S, Gastaldelli A, Greco AV, Mingrone G, Ferrannini E.

    Diabetes. 2005 Aug;54(8):2382-9.PMID: 16046305 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes.

    Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, Bajaj M, Mandarino L, DeFronzo R, Cusi K.

    Diabetes. 2003 Oct;52(10):2461-74.PMID: 14514628 [PubMed - indexed for MEDLINE]Related articlesFree article